Showing results (51-60 of 200) with videos related to
Sort By:
Pageof 20
Seminars in Oncology|December 1, 1992
Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary siteF A Greco, D H Johnson, J D HainsworthSeminars in Oncology|August 1, 1995
Paclitaxel by 1-hour infusion in combination chemotherapy of stage III non-small cell lung cancerF A Greco, S L Stroup, J D HainsworthJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancerJ D Hainsworth, D S Thompson, F A GrecoSeminars in Oncology|April 1, 1992
The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary siteJ D Hainsworth, D H Johnson, F A GrecoSeminars in Oncology|December 1, 1992
Chronic etoposide schedules in the treatment of non-Hodgkin's lymphomaJ D Hainsworth, D H Johnson, F A GrecoChest|November 1, 1982
Pancoast's syndrome and small cell lung cancerD H Johnson, J D Hainsworth, F A GrecoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary siteJ D Hainsworth, W J Lennington, F A GrecoSeminars in Oncology|February 1, 1990
Chronic daily administration of oral etoposideF A Greco, D H Johnson, J D HainsworthSeminars in Oncology|August 7, 1999
Weekly administration of docetaxel (Taxotere): summary of clinical dataJ D Hainsworth, H A Burris, F A GrecoAmerican Journal of Clinical Oncology|April 1, 1988
Curative combination chemotherapy for patients with advanced poorly differentiated carcinoma of unknown primary siteJ D Hainsworth, T W Dial, F A GrecoPageof 20